Macrophages Versus Escherichia coli: A Decisive Fight in Crohn's Disease

Anthony Buisson1, Marie-Agnès Bringer, Nicolas Barnich

  • 1*Clermont Université, UMR 1071 Inserm/Université d'Auvergne, USC-INRA 2018, Clermont-Ferrand, France; †Department of Hepato-Gastroenterology, University Hospital Estaing of Clermont-Ferrand, Université d'Auvergne, Clermont-Ferrand, France; and ‡INRA UMR1324, CNRS UMR6265, University of Bourgogne Franche-Comté, Centre des Sciences du Goût et de l'Alimentation, Dijon, France.

Insights

This review explores the role of intestinal macrophages in Crohn's disease (CD) pathogenesis. Targeting these immune cells offers a promising strategy to improve gut health and alter the disease

Area of Science:

  • Immunology
  • Gastroenterology
  • Microbiology

Background:

  • Crohn's disease (CD) pathophysiology is not fully understood, limiting treatment options.
  • Current hypotheses suggest CD arises from aberrant interactions between gut microbiota and the host immune system.
  • Intestinal macrophages are increasingly implicated in CD etiology, with increased numbers and granuloma formation observed in patients.

Purpose of the Study:

  • To review the current understanding of intestinal macrophage function in Crohn's disease.
  • To examine the interaction between macrophages and CD-associated Escherichia coli.
  • To discuss the impact of existing CD therapies on intestinal macrophages.

Main Methods:

  • Literature review of experimental and genetic evidence.
  • Analysis of studies focusing on macrophage roles in CD.
  • Examination of macrophage-pathogen interactions and therapeutic effects.

Main Results:

  • Macrophages are central players in the inflammatory processes of Crohn's disease.
  • Defective macrophage responses to pathogens like Escherichia coli may contribute to CD.
  • CD therapies can influence macrophage behavior and function.

Conclusions:

  • Modulating intestinal macrophages presents a potential therapeutic avenue for Crohn's disease.
  • Targeting macrophages could lead to significant advancements in altering the intestinal damage in CD.
  • Further research into macrophage modulation may promote gut health and improve patient outcomes.

Related Concept Videos

Defense Against Bacterial Pathogens01:31

Defense Against Bacterial Pathogens

The human immune system is a complex network of cells, tissues, and organs that work together to defend the body against bacterial infections. It consists of various immune cells, each playing a specific role in the defense mechanism.
Phagocytes
Phagocytes are the frontline soldiers of the immune system. They include neutrophils and macrophages. Neutrophils are the most abundant type of white blood cell and are quickly mobilized to the site of infection. Macrophages are larger cells that patrol...
3.3K
Inflammatory Bowel Disease II: Crohn's Disease01:30

Inflammatory Bowel Disease II: Crohn's Disease

Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
1.4K
Immune Surveillance by NK Cells and Phagocytes01:25

Immune Surveillance by NK Cells and Phagocytes

Immune surveillance is an integral part of the innate immune system, involving the continuous monitoring of peripheral tissues to detect and respond to pathogens, infected cells, or cancerous cells. This surveillance is conducted primarily by natural killer (NK) cells and phagocytes, which employ distinct but complementary mechanisms to identify and eliminate threats.
Natural Killer Cells: The Fast Responders
NK cells are large granular lymphocytes found in the blood and lymphatic system. These...
9.3K